New approaches for understanding mechanisms of drug resistance in schistosomes

Parasitology

Volumn 140, Issue 12, 2013, Pages 1534-1546

  Greenberg, Robert M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

drug resistance; multidrug transporters; praziquantel; schistosomiasis

Indexed keywords

IVERMECTIN; PRAZIQUANTEL; TRICLABENDAZOLE;

ANTIBIOTIC RESISTANCE; DRUG EFFICACY; DRUG TREATMENT FAILURE; GENE EXPRESSION REGULATION; GENOME; HUMAN; MONITORING; NONHUMAN; PARASITE ISOLATION; PLATYHELMINTH; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TRANSCRIPTOMICS; TRANSGENICS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHROMOSOME MAPPING; DRUG RESISTANCE; GENOMICS; HELMINTH PROTEINS; HUMANS; NEGLECTED DISEASES; PRAZIQUANTEL; RNA INTERFERENCE; SCHISTOSOMA; SCHISTOSOMIASIS; SCHISTOSOMICIDES;

EID: 84883676962     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182013000231     Document Type: Review

References (167)

1. Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L. and Chang, G. (2009). Structure of P-glycoprotein reveals a molecular basis for polyspecific drug binding. Science 323, 1718-1722. doi: 10.1126/science.1168750.
2. Alonso, D., Munoz, J., Gascon, J., Valls, M. E. and Corachan, M. (2006). Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. American Journal of Tropical Medicine and Hygiene 74, 342-344.
3. Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E. and Gottesman, M. M. (2003). P-glycoprotein: from genomics to mechanism. Oncogene 22, 7468-7485.
4. Andrews, P., Thomas, H., Pohlke, R. and Seubert, J. (1983). Praziquantel. Medicinal Research Reviews 3, 147-200.
5. Aragon, A. D., Imani, R. A., Blackburn, V. R., Cupit, P. M., Melman, S. D., Goronga, T., Webb, T., Loker, E. S. and Cunningham, C. (2009). Towards an understanding of the mechanism of action of praziquantel. Molecular and Biochemical Parasitology 164, 57-65. doi: 10.1016/j.molbiopara.2008.11.007.
6. Ardelli, B. F. and Prichard, R. K. (2013). Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin. Veterinary Parasitology 191, 264-275. doi: 10.1016/j.vetpar.2012.09.021.
7. Bartley, D. J., McAllister, H., Bartley, Y., Dupuy, J., Menez, C., Alvinerie, M., Jackson, F. and Lespine, A. (2009). P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus. Parasitology 136, 1081-1088. doi: 10.1017/S0031182009990345.
8. Beckmann, S. and Grevelding, C. G. (2012). Paving the way for transgenic schistosomes. Parasitology 139, 651-668. doi: 10.1017/S0031182011001466.
9. Behbehani, M. and Savioli, L. (1998). Report of the WHO informal consultation on monitoring of drug efficacy in the control of schistosomiasis and intestinal nematodes.WHO/CDS/CPC/SIP/99.1.WorldHealthOrganization, Geneva.
10. Bhardwaj, R., Krautz-Peterson, G., Da'dara, A., Tzipori, S. and Skelly, P. J. (2011). Tegumental phosphodiesterase SmNPP-5 is a virulence factor for schistosomes. Infection and Immunity 79, 4276-4284. doi: 10.1128/IAI.05431-11.
11. Blackmore, C. G., McNaughton, P. A. and Van Veen, H.W. (2001). Multidrug transporters in prokaryotic and eukaryotic cells: physiological functions and transport mechanisms. Molecular Membrane Biology 18, 97-103.
12. Blanton, R. E., Blank, W. A., Costa, J. M., Carmo, T. M., Reis, E. A., Silva, L. K., Barbosa, L. M., Test, M. R. and Reis, M. G. (2011). Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil. International Journal for Parasitology 41, 1093-1099. doi: 10.1016/j.ijpara. 2011.06.002.
13. Boray, J. C., Crowfoot, P. D., Strong, M. B., Allison, J. R., Schellembaum, M., von Orelli, M. and Sarasin, G. (1983). Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Veterinary Record 113, 315-317.
14. Borst, P. and Elferink, R. O. (2002). Mammalian ABC transporters in health and disease. Annual Review of Biochemistry 71, 537-592.
15. Bosch, I. B., Wang, Z. X., Tao, L. F. and Shoemaker, C. B. (1994). Two Schistosoma mansoni cDNAs encoding ATP-binding cassette (ABC) family proteins. Molecular and Biochemical Parasitology 65, 351-356.
16. Botros, S., Sayed, H., Amer, N., El-Ghannam, M., Bennett, J. L. and Day, T.A. (2005). Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. International Journal for Parasitology 35, 787-791.
17. Brehm, K. (2010). Echinococcus multilocularis as an experimental model in stem cell research and molecular host-parasite interaction. Parasitology 137, 537-555. doi: 10.1017/S0031182009991727.
18. Brindley, P. J. (1994). Relationships between chemotherapy and immunity in schistosomiasis. Advances in Parasitology 34, 133-161.
19. Brindley, P. J. and Sher, A. (1987). The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. Journal of Immunology 139, 215-220.
20. Britton, C., Samarasinghe, B. and Knox, D. P. (2012). Ups and downs of RNA interference in parasitic nematodes. Experimental Parasitology 132, 56-61. doi: 10.1016/j.exppara.2011.08.002.
21. Caffrey, C. R., Rohwer, A., Oellien, F., Marhofer, R. J., Braschi, S., Oliveira, G., McKerrow, J. H. and Selzer, P. M. (2009). A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, Schistosoma mansoni. PLoS ONE 4, e4413. doi: 10.1371/journal. pone.0004413.
22. Cantacessi, C., Campbell, B. E., Jex, A. R., Young, N. D., Hall, R. S., Ranganathan, S. and Gasser, R. B. (2012). Bioinformatics meets parasitology. Parasite Immunology 34, 265-275. doi: 10.1111/j.1365-3024. 2011.01304.x.
23. Cheng, G., Fu, Z., Lin, J., Shi, Y., Zhou, Y., Jin, Y. and Cai, Y. (2009). In vitro and in vivo evaluation of small interference RNA-mediated gynaecophoral canal protein silencing in Schistosoma japonicum. Journal of Gene Medicine 11, 412-421. doi: 10.1002/jgm.1314.
24. Cioli, D. (2000). Praziquantel: is there real resistance and are there alternatives? Current Opinion in Infectious Diseases 13, 659-663.
25. Cioli, D. and Pica-Mattoccia, L. (1984). Genetic analysis of hycanthone resistance in Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene 33, 80-88.
26. Cioli, D. and Pica-Mattoccia, L. (2003). Praziquantel. Parasitology Research 90(Supp. 1), S3-S9.
27. Cioli, D. and Pica-Mattoccia, L. (2005). Current and future antischistosomal drugs. In Schistosomiasis (ed. Secor, W. E. and Colley, D. G.), pp. 191-206. Springer, New York, NY.
28. Cioli, D., Pica-Mattoccia, L. and Moroni, R. (1992). Schistosoma mansoni: hycanthone/oxamniquine resistance is controlled by a single autosomal recessive gene. Experimental Parasitology 75, 425-432.
29. Cioli, D., Pica-Mattoccia, L. and Archer, S. (1993). Drug resistance in schistosomes. Parasitology Today 9, 162-166.
30. Cioli, D., Pica-Mattoccia, L. and Archer, S. (1995). Antischistosomal drugs: past, present. . .and future? Pharmacology and Therapeutics 68, 35-85.
31. Coles, G. C. and Kinoti, G.K. (1997). Defining resistance in Schistosoma. Parasitology Today 13, 157-158.
32. Collins, J. J., King, R. S., Cogswell, A., Williams, D. L. and Newmark, P. A. (2011). An atlas for Schistosoma mansoni organs and life-cycle stages using cell type-specific markers and confocal microscopy. PLoS Neglected Tropical Diseases 8, e1009. doi: 10.1371/journal. pntd.0001009.
33. Collins, J. J., Wang, B., Lambrus, B. G., Tharp, M. E., Iver, H. and Newmark, P. A. (2013). Adult somatic stem cells in the human parasite Schistosoma Mansoni. Nature 494, 476-479. doi: 10.1038/nature 11924.
34. Cooper, L. A., Lewis, F. A. and File-Emperador, S. (1989). Reestablishing a life cycle of Schistosoma mansoni from cryopreserved larvae. Journal of Parasitology 75, 353-356.
35. Couto, F. F., Coelho, P. M., Araujo, N., Kusel, J. R., Katz, N., Jannotti-Passos, L. K. and Mattos, A. C. (2011). Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails. Memorias do Instituto Oswaldo Cruz 106, 153-157.
36. Couto, F. F., Coelho, P. M., Araujo, N., Kusel, J. R., Katz, N. and Mattos, A. C. (2010). Use of fluorescent probes as a useful tool to identify resistant Schistosoma mansoni isolates to praziquantel. Parasitology 137, 1791-1797. doi: 10.1017/S003118201000065X.
37. Criscione, C. D., Valentim, C. L. L., Hirai, H., LoVerde, P. T. and Anderson, T. J. C. (2009). Genomic linkage map of the human blood fluke Schistosoma mansoni. Genome Biology 10, R71. doi: 10.1186/gb-2009-10-6-r71.
38. Crisford, A., Murray, C., O'Connor, V., Edwards, R. J., Kruger, N., Welz, C., von Samson-Himmelstjerna, G., Harder, A., Walker, R. J. and Holden-Dye, L. (2011). Selective toxicity of the anthelmintic emodepside revealed by heterologous expression of human KCNMA1 in Caenorhabditis elegans. Molecular Pharmacology 79, 1031-1043. doi: 10.1124/mol.111.071043.
39. Cvilink, V., Lamka, J. and Skalova, L. (2009). Xenobiotic metabolizing enzymes and metabolism of anthelminthics in helminths. Drug Metabolism Reviews 41, 8-26. doi: 10.1080/03602530802602880.
40. Danso-Appiah, A. and De Vlas, S. J. (2002). Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends in Parasitology 18, 125-129.
41. Dassa, E. and Bouige, P. (2001). The ABC of ABCs: a phylogenetic and functional classification of ABC systems in living organisms. Research in Microbiology 152, 211-229.
42. Day, T.A. and Botros, S. (2006). Drug resistance in schistosomes. In Parasitic Flatworms: Molecular Biology, Biochemistry, Immunology and Physiology (ed. Maule, A. and Marks, N. J.), pp. 256-268. CAB International, Oxfordshire, UK.
43. Dean, M. and Annilo, T. (2005). Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annual Review of Genomics and Human Genetics 6, 123-142.
44. Dean, M., Rzhetsky, A. and Allikmets, R. (2001). The human ATPbinding cassette (ABC) transporter superfamily. Genome Research 11, 1156-1166. doi: 10.1101/gr.184901.
45. Dent, J. A., McHardy, M. S., Vassilatis, D. M. and Avery, L. (2000). The genetics of ivermectin resistance in Caenorhabditis elegans. Proceedings of the National Academy of Sciences, USA 97, 2674-2679.
46. Devaney, E., Winter, A. D. and Britton, C. (2010). microRNAs: a role in drug resistance in parasitic nematodes? Trends in Parasitology 26, 428-433. doi: 10.1016/j.pt.2010.05.003.
47. Doenhoff, M. J., Cioli, D. and Utzinger, J. (2008). Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Current Opinion in Infectious Diseases 21, 659-667. doi: 10.1097/QCO. 0b013e328318978f.
48. Doenhoff, M. J., Coles, G. C., Pica-Mattoccia, L. and Wheatcroft-Francklow, K. (2009a). Chemotherapy and drug resistance in schistosomiasis, fascioliasis and tapeworm infections. In Antimicrobial Drug Resistance, Vol. 1: Mechanisms of Drug Resistance, Vol. 1 (ed. Mayers, D. L.), pp. 629-646. Humana Press, Totowa, NJ.
49. Doenhoff, M. J., Hagan, P., Cioli, D., Southgate, V., Pica-Mattoccia, L., Botros, S., Coles, G., Tchuem Tchuente, L. A., Mbaye, A. and Engels, D. (2009b). Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 136, 1825-1835. doi: 10.1017/S0031182009000493.
50. Doenhoff, M. J. and Pica-Mattoccia, L. (2006). Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Review of Anti-infective Therapy 4, 199-210.
51. Doenhoff, M. J., Sabah, A. A., Fletcher, C., Webbe, G. and Bain, J. (1987). Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 947-951.
52. Duvoisin, R., Ayuk, M. A., Rinaldi, G., Suttiprapa, S., Mann, V. H., Lee, C. M., Harris, N. and Brindley, P. J. (2012). Human U6 promoter drives stronger shRNA activity than its schistosome orthologue in Schistosoma mansoni and human fibrosarcoma cells. Transgenic Research 21, 511-521. doi: 10.1007/s11248-011- 9548-0.
53. Eisenhoffer, G. T., Kang, H. and Sanchez Alvarado, A. (2008). Molecular analysis of stem cells and their descendants during cell turnover and regeneration in the planarian Schmidtea mediterranea. Cell Stem Cell 3, 327-339. doi: 10.1016/j.stem.2008.07.002.
54. Fairweather, I. (2011). Liver fluke isolates: a question of provenance. Veterinary Parasitology 176, 1-8. doi: 10.1016/j.vetpar.2010.12.011.
55. Fallon, P. G. (1995). Short report: diminished susceptibility to praziquantel in a senegal isolate of Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene 53, 61-62.
56. Fallon, P. G. (1998). Schistosome resistance to praziquantel. Drug Resistance Updates 1, 236-241.
57. Fallon, P. G. and Doenhoff, M. J. (1994). Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. American Journal of Tropical Medicine and Hygiene 51, 83-88.
58. Fallon, P. G., Mubarak, J. S., Fookes, R. E., Niang, M., Butterworth, A. E., Sturrock, R. F. and Doenhoff, M.J. (1997). Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Experimental Parasitology 86, 29-36.
59. Fallon, P. G., Tao, L. F., Ismail, M. M. and Bennett, J. L. (1996). Schistosome resistance to praziquantel: Fact or artifact? Parasitology Today 12, 316-320.
60. Gimenez-Bonafe, P., Guillen Canovas, A., Ambrosio, S., Tortosa, A. and Perez-Tomas, R. (2008). Drugs modulating MDR. (ed. Colabufo, N. A.), pp. 63-99.
61. Research Signpost, Kerala, India. Gonnert, R. and Andrews, P. (1977). Praziquantel, a new broad-spectrum antischistosomal agent. Zeitschrift für Parasitenkunde 52, 129-150.
62. Greenberg, R. M. (2005). Are Ca2+ channels targets of praziquantel action? International Journal for Parasitology 35, 1-9.
63. Gryseels, B., Mbaye, A., De Vlas, S. J., Stelma, F. F., Guisse, F., Van Lieshout, L., Faye, D., Diop, M., Ly, A., Tchuem-Tchuente, L. A., Engels, D. and Polman, K. (2001). Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Tropical Medicine and International Health 6, 864-873.
64. Gryseels, B., Stelma, F. F., Talla, I., van Dam, G. J., Polman, K., Sow, S., Diaw, M., Sturrock, R. F., Doehring-Schwerdtfeger, E., Kardorff, R., Decam, C., Niang, M. and Deelder, A.M. (1994). Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Tropical and Geographical Medicine 46, 209-219.
65. Hayeshi, R., Masimirembwa, C., Mukanganyama, S. and Ungell, A. L. (2006). The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. European Journal of Pharmaceutical Sciences 29, 70-81.
66. Herwaldt, B. L., Tao, L. F., van Pelt, W., Tsang, V. C. and Bruce, J. I. (1995). Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel. Clinical Infectious Diseases 20, 309-315.
67. Higgins, C. F. (2007). Multiple molecular mechanisms for multidrug resistance transporters. Nature 446, 749-757.
68. Hines-Kay, J., Cupit, P. M., Sanchez, M. C., Rosenberg, G. H., Hanelt, B. and Cunningham, C. (2012). Transcriptional analysis of Schistosoma mansoni treated with praziquantel in vitro. Molecular and Biochemical Parasitology 186, 87-94. doi: 10.1016/j.molbiopara.2012.09.006.
69. Hotez, P. J. and Fenwick, A. (2009). Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Neglected Tropical Diseases 3, e485. doi: 10.1371/journal.pntd.0000485.
70. Ismail, M., Botros, S., Metwally, A., William, S., Farghally, A., Tao, L. F., Day, T. A. and Bennett, J. L. (1999). Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. American Journal of Tropical Medicine and Hygiene 60, 932-935.
71. Ismail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L. F. and Bennett, J. L. (1996). Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. American Journal of Tropical Medicine and Hygiene 55, 214-218.
72. James, C. E., Hudson, A. L. and Davey, M.W. (2009). Drug resistance mechanisms in helminths: is it survival of the fittest? Trends in Parasitology 25, 328-335. doi: 10.1016/j.pt.2009.04.004.
73. Jin, M. S., Oldham, M. L., Zhang, Q. and Chen, J. (2012). Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans. Nature 490, 566-569. doi: 10.1038/nature11448.
74. Jones, P. M. and George, A. M. (2005). Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling. International Journal for Parasitology 35, 555-566.
75. Kartner, N., Riordan, J. R. and Ling, V. (1983). Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221, 1285-1288.
76. Kasinathan, R. S., Goronga, T., Messerli, S. M., Webb, T. R. and Greenberg, R. M. (2010a). Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel. FASEB Journal 24, 128-135. doi: 10.1096/fj.09-137091.
77. Kasinathan, R. S. and Greenberg, R. M. (2012). Pharmacology and potential physiological significance of schistosome multidrug resistance transporters. Experimental Parasitology 132, 2-6. doi: 10.1016/j.exppara. 2011.03.004.
78. Kasinathan, R. S., Morgan, W. M. and Greenberg, R. M. (2010b). Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel. Molecular and Biochemical Parasitology 173, 25-31. doi: 10.1016/j.molbiopara. 2010.05.003.
79. Kasinathan, R. S., Morgan, W. M. and Greenberg, R. M. (2011). Genetic knockdown and pharmacological inhibition of parasite multidrug resistance transporters disrupts egg production in Schistosoma mansoni. PLoS Neglected Tropical Diseases 5, e1425. doi: 10.1371/journal.pntd. 0001425.
80. Keiser, J. and Utzinger, J. (2012). Antimalarials in the treatment of schistosomiasis. Current Pharmaceutical Design 18, 3531-3538.
81. Kerboeuf, D., Blackhall, W., Kaminsky, R. and von Samson-Himmelstjerna, G. (2003). P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance. International Journal of Antimicrobial Agents 22, 332-346.
82. King, C. H. (2010). Parasites and poverty: the case of schistosomiasis. Acta Tropica 113, 95-104. doi: 10.1016/j.actatropica.2009.11.012.
83. Kongs, A., Marks, G., Verle, P. and Van der Stuyft, P. (2008). The unreliability of the Kato-Katz technique limits its usefulness for evaluating S. mansoni infections. Tropical Medicine and International Health 6, 163-169. doi: 10.1046/j.1365-3156.2001.00687.x.
84. Krautz-Peterson, G., Bhardwaj, R., Faghiri, Z., Tararam, C. A. and Skelly, P. J. (2010). RNA interference in schistosomes: machinery and methodology. Parasitology 137, 485-495. doi: 10.1017/S0031182009991168.
85. Kumkate, S., Chunchob, S. and Janvilisri, T. (2008). Expression of ATP-binding cassette multidrug transporters in the giant liver fluke Fasciola gigantica and their possible involvement in the transport of bile salts and anthelmintics. Molecular and Cellular Biochemistry 317, 77-84. doi: 10.1007/s11010-008-9833-2.
86. Kusel, J. R., Oliveira, F. A., Todd, M., Ronketti, F., Lima, S. F., Mattos, A. C., Reis, K. T., Coelho, P. M., Thornhill, J. A. and Ribeiro, F. (2006). The effects of drugs, ions, and poly-l-lysine on the excretory system of Schistosoma mansoni. Memorias do Instituto Oswaldo Cruz 101, 293-298.
87. Kwa, M. S. G., Veenstra, J. G., Dijk, M. V. and Roos, M. H. (1995). Tubulin genes from the parasitic nematode Haemonchus contortus modulate drug resistance in Caenorhabditis elegans. Journal of Molecular Biology 246, 500-510.
88. Leprohon, P., Legare, D. and Ouellette, M. (2011). ABC transporters involved in drug resistance in human parasites. Essays in Biochemistry 50, 121-144. doi: 10.1042/bse0500121.
89. Lespine, A., Menez, C., Bourguinat, C. and Prichard, R. K. (2012). P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing transportdependent anthelmintic resistance. International Journal for Parasitology: Drugs and Drug Resistance 2, 58-75. doi: 10.1016/j.ijpddr.2011.10.001.
90. Liang, Y. S., Coles, G. C., Dai, J. R., Zhu, Y. C. and Doenhoff, M.J. (2001). Biological characteristics of praziquantel-resistant and-susceptible isolates of Schistosoma mansoni. Annals of Tropical Medicine and Parasitology 95, 715-723.
91. Liang, Y. S., Dai, J. R., Zhu, Y. C., Coles, G. C. and Doenhoff, M.J. (2003). Genetic analysis of praziquantel resistance in Schistosoma mansoni. Southeast Asian Journal of Tropical Medicine and Public Health 34, 274-280.
92. Liang, Y. S., Li, H. J., Dai, J. R., Wang, W., Qu, G. L., Tao, Y. H., Xing, Y. T., Li, Y. Z., Qian, K. and Wei, J. Y. (2011). Studies on resistance of Schistosoma to praziquantel XIII: resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory. Chinese Journal of Schistosomiasis Control 23, 605-610.
93. Lin, D. D., Liu, J. X., Liu, Y. M., Hu, F., Zhang, Y. Y., Xu, J. M., Li, J. Y., Ji, M. J., Bergquist, R., Wu, G. L. and Wu, H.W. (2008). Routine Kato-Katz technique underestimates the prevalence of Schistosoma japonicum: a case study in an endemic area of the People's Republic of China. Parasitology International 57, 281-286. doi: 10.1016/j.parint.2008. 04.005.
94. Mattos, A. C., Pereira, G. C., Jannotti-Passos, L. K., Kusel, J. R. and Coelho, P. M. (2007). Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni. Acta Tropica 102, 84-91.
95. Mealey, K. L., Bentjen, S. A., Gay, J.M. and Cantor, G. H. (2001). Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11, 727-733.
96. Melman, S. D., Steinauer, M. L., Cunningham, C., Kubatko, L. S., Mwangi, I. N., Wynn, N. B., Mutuku, M.W., Karanja, D. M., Colley, D. G., Black, C. L., Secor, W. E., Mkoji, G. M. and Loker, E. S. (2009). Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Neglected Tropical Diseases 3, e504. doi: 10.1371/journal.pntd.0000504.
97. Messerli, S. M., Kasinathan, R. S., Morgan, W., Spranger, S. and Greenberg, R. M. (2009). Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility. Molecular and Biochemical Parasitology 167, 54-59. doi: 10.1016/j.molbiopara.2009.04.007.
98. Mizutani, T., Masuda, M., Nakai, E., Furumiya, K., Togawa, H., Nakamura, Y., Kawai, Y., Nakahira, K., Shinkai, S. and Takahashi, K. (2008). Genuine functions of P-glycoprotein (ABCB1). Current Drug Metabolism 9, 167-174.
99. Molento, M. B. and Prichard, R. K. (1999). Effects of the multidrugresistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus). Parasitology Research 85, 1007-1011.
100. Moll, L., Gaasenbeek, C. P., Vellema, P. and Borgsteede, F. H. (2000). Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands. Veterinary Parasitology 91, 153-158.
101. Mourao, M. M., Dinguirard, N., Franco, G. R. and Yoshino, T. P. (2009). Phenotypic screen of early-developing larvae of the blood fluke, Schistosoma mansoni, using RNA interference. PLoS Neglected Tropical Diseases 3, e502. doi: 10.1371/journal.pntd.0000502.
102. Mutapi, F., Rujeni, N., Bourke, C., Mitchell, K., Appleby, L., Nausch, N., Midzi, N. and Mduluza, T. (2011). Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel. PLoS Neglected Tropical Diseases 5, e1143. doi: 10.1371/journal.pntd.0001143.
103. Nogi, T., Zhang, D., Chan, J. D. and Marchant, J. S. (2009). A novel biological activity of praziquantel requiring voltage-operated Ca2+ channel subunits: subversion of flatworm regenerative polarity. PLoS Neglected Tropical Diseases 3, e464. doi: 10.1371/journal.pntd.0000464.
104. Novozhilova, E., Kimber, M. J., Qian, H., McVeigh, P., Robertson, A. P., Zamanian, M., Maule, A. G. and Day, T. A. (2010). FMRFamide-like peptides (FLPs) enhance voltage-gated calcium currents to elicit muscle contraction in the human parasite Schistosoma mansoni. PLoS Neglected Tropical Diseases 4, e790. doi: 10.1371/journal. pntd.0000790.
105. Oliveira, F. A., Kusel, J. R., Ribeiro, F. and Coelho, P. M. (2006). Responses of the surface membrane and excretory system of Schistosoma mansoni to damage and to treatment with praziquantel and other biomolecules. Parasitology 132, 321-330.
106. Paulsen, I. T. (2003). Multidrug efflux pumps and resistance: regulation and evolution. Current Opinion in Microbiology 6, 446-451.
107. Pereira, C., Fallon, P. G., Cornette, J., Capron, A., Doenhoff,M. J. and Pierce, R. J. (1998). Alterations in cytochrome-c oxidase expression between praziquantel-resistant and susceptible strains of Schistosoma mansoni. Parasitology 117(Pt 1), 63-73.
108. Pereira, T. C., Pascoal, V. D., Marchesini, R. B., Maia, I. G., Magalhaes, L. A., Zanotti-Magalhaes, E. M. and Lopes-Cendes, I. (2008). Schistosoma mansoni: evaluation of an RNAi-based treatment targeting HGPRTase gene. Experimental Parasitology 118, 619-623. doi: 10.1016/j.exppara.2007.11. 017.
109. Pica-Mattoccia, L., Archer, S. and Cioli, D. (1992). Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules. Molecular and Biochemical Parasitology 55, 167-175.
110. Pica-Mattoccia, L. and Cioli, D. (2004). Sex-and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. International Journal for Parasitology 34, 527-533.
111. Pica-Mattoccia, L., Doenhoff, M. J., Valle, C., Basso, A., Troiani, A. R., Liberti, P., Festucci, A., Guidi, A. and Cioli, D. (2009). Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni. Acta Tropica 111, 82-85. doi: 10.1016/j. actatropica.2009.01.012.
112. Pica-Mattoccia, L., Orsini, T., Basso, A., Festucci, A., Liberti, P., Guidi, A., Marcatto-Maggi, A. L., Nobre-Santana, S., Troiani, A. R., Cioli, D. and Valle, C. (2008). Schistosoma mansoni: lack of correlation between praziquantel-induced intra-worm calcium influx and parasite death. Experimental Parasitology 119, 332-335. doi: 10.1016/j.exppara.2008.03.012.
113. Pica-Mattoccia, L., Novi, A. and Cioli, D. (1997). Enzymatic basis for the lack of oxamniquine activity in Schistosoma haematobium infections. Parasitology Research 83, 687-689.
114. Pica-Mattoccia, L., Valle, C., Basso, A., Troiani, A. R., Vigorosi, F., Liberti, P., Festucci, A. and Cioli, D. (2007). Cytochalasin D abolishes the schistosomicidal activity of praziquantel. Experimental Parasitology 115, 344-351.
115. Pommier, Y., Pourquier, P., Urasaki, Y., Wu, J. and Laco, G. S. (1999). Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resistance Updates 2, 307-318.
116. Pommier, Y., Sordet, O., Antony, S., Hayward, R. L. and Kohn, K.W. (2004). Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23, 2934-2959.
117. Prichard, R. K., Hall, C. A., Kelly, J. D., Martin, I. C. and Donald, A. D. (1980). The problem of anthelmintic resistance in nematodes. Australian Veterinary Journal 56, 239-251.
118. Protasio, A. V., Tsai, I. J., Babbage, A., Nichol, S., Hunt, M., Aslett, M. A., De Silva, N., Velarde, G. S., Anderson, T. J., Clark, R. C., Davidson, C., Dillon, G. P., Holroyd, N. E., LoVerde, P. T., Lloyd, C., McQuillan, J., Oliveira, G., Otto, T. D., Parker-Manuel, S. J., Quail, M. A., Wilson, R. A., Zerlotini, A., Dunne, D.W. and Berriman, M. (2012). A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Neglected Tropical Diseases 6, e1455. doi: 10.1371/journal.pntd. 0001455.
119. Quack, T., Wippersteg, V. and Grevelding, C. G. (2010). Cell cultures for schistosomes-chances of success or wishful thinking? International Journal for Parasitology 40, 991-1002. doi: 10.1016/j.ijpara.2010.04.013.
120. Redman, C. A., Robertson, A., Fallon, P. G., Modha, J., Kusel, J. R., Doenhoff, M. J. and Martin, R. J. (1996). Praziquantel: an urgent and exciting challenge. Parasitology Today 12, 14-20.
121. Rinaldi, G., Eckert, S. E., Tsai, I. J., Suttiprapa, S., Kines, K. J., Tort, J. F., Mann, V. H., Turner, D. J., Berriman,M. and Brindley, P. J. (2012a). Germline transgenesis and insertional mutagenesis in Schistosoma mansoni mediated by murine leukemia virus. PloS Pathogens 8, e1002820. doi: 10.1371/journal.ppat.1002820.
122. Rinaldi, G., Suttiprapa, S., Tort, J. F., Folley, A. E., Skinner, D. E. and Brindley, P. J. (2012b). An antibiotic selection marker for schistosome transgenesis. International Journal for Parasitology 42, 123-130. doi: 10.1016/j.ijpara.2011.11.005.
123. Sabah, A. A., Fletcher, C., Webbe, G. and Doenhoff, M.J. (1986). Schistosoma mansoni: chemotherapy of infections of different ages. Experimental Parasitology 61, 294-303.
124. Sabra, A. N. and Botros, S. S. (2008). Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure. Journal of Parasitology 94, 537-541. doi: 10.1645/GE-1297.1.
125. Saier, M. H. and Paulsen, I. T. (2001). Phylogeny of multidrug transporters. Seminars in Cell and Developmental Biology 12, 205-213.
126. Sato, H., Kusel, J. R. and Thornhill, J. (2002). Functional visualization of the excretory system of adult Schistosoma mansoni by the fluorescent marker resorufin. Parasitology 125, 527-535.
127. Sato, H., Kusel, J. R. and Thornhill, J. (2004). Excretion of fluorescent substrates of mammalian multidrug resistance-associated protein (MRP) in the Schistosoma mansoni excretory system. Parasitology 128, 43-52.
128. Sayed, A. A., Simeonov, A., Thomas, C. J., Inglese, J., Austin, C. P. and Williams, D. L. (2008). Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nature Medicine 14, 407-412. doi: 10.1038/nm1737.
129. Schinkel, A. H., Smit, J. J., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P., Berns, A. J. M. and Borst, P. (1994). Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
130. Selkirk, M. E., Huang, S. C., Knox, D. P. and Britton, C. (2012). The development of RNA interference (RNAi) in gastrointestinal nematodes. Parasitology 139, 605-612. doi: 10.1017/S0031182011002332.
131. Seto, E. Y., Wong, B. K., Lu, D. and Zhong, B. (2011). Human schistosomiasis resistance to praziquantel in China: should we be worried? American Journal of Tropical Medicine and Hygiene 85, 74-82. doi: 10.4269/ajtmh.2011.10-0542.
132. Silva, I. M., Thiengo, R., Conceição, M. J., Rey, L., Lenzi, H. L., Perreira Filho, E. and Ribeiro, P. C. (2005). Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa. Memorias do Instituto Oswaldo Cruz 100, 445-449.
133. Sioud, M. (2011). Promises and challenges in developing RNAi as a research tool and therapy. Methods in Molecular Biology 703, 173-187. doi: 10.1007/978-1-59745-248-9-12.
134. Smout, M. J., Kotze, A. C., McCarthy, J. S. and Loukas, A. (2010). A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility. PLoS Neglected Tropical Diseases 4, e885. doi: 10.1371/journal.pntd.0000885.
135. Stefanic, S., Dvorak, J., Horn, M., Braschi, S., Sojka, D., Ruelas, D. S., Suzuki, B., Lim, K. C., Hopkins, S. D., McKerrow, J.H. and Caffrey, C. R. (2010). RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening. PLoS Neglected Tropical Diseases 4, e850. doi: 10.1371/journal.pntd.0000850.
136. Stelma, F. F., Sall, S., Daff, B., Sow, S., Niang, M. and Gryseels, B. (1997). Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low. Journal of Infectious Diseases 176, 304-307.
137. Stelma, F. F., Talla, I., Sow, S., Kongs, A., Niang, M., Polman, K., Deelder, A.M. and Gryseels, B. (1995). Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene 53, 167-170.
138. Suttiprapa, S., Rinaldi, G. and Brindley, P. J. (2012). Genetic manipulation of schistosomes-Progress with integration competent vectors. Parasitology 139, 641-650. doi: 10.1017/S003118201100134X.
139. Swain, M. T., Larkin, D. M., Caffrey, C. R., Davies, S. J., Loukas, A., Skelly, P. J. and Hoffmann, K. F. (2011). Schistosoma comparative genomics: integrating genome structure, parasite biology and anthelmintic discovery. Trends in Parasitology 27, 555-564. doi: 10.1016/j.pt.2011.09.003.
140. Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C. and Gottesman, M. M. (2006). Targeting multidrug resistance in cancer. Nature Reviews: Drug Discovery 5, 219-234.
141. Tchoubrieva, E. B. and Kalinna, B. (2010). Advances in mRNA silencing and transgene expression: a gateway to functional genomics in schistosomes. Biotechnology and Genetic Engineering Reviews 26, 261-280.
142. Tchoubrieva, E. B., Ong, P. C., Pike, R. N., Brindley, P. J. and Kalinna, B. H. (2010). Vector-based RNA interference of cathepsin B1 in Schistosoma mansoni. Cellular and Molecular Life Sciences 67, 3739-3748. doi: 10.1007/s00018-010-0345-3.
143. Tompkins, J. B., Stitt, L. E., Morrissette, A.M. and Ardelli, B. F. (2011). The role of Brugia malayi ATP-binding cassette (ABC) transporters in potentiating drug sensitivity. Parasitology Research 109, 1311-1322. doi: 10.1007/s00436-011-2378-4.
144. Toure, S., Zhang, Y., Bosque-Oliva, E., Ky, C., Ouedraogo, A., Koukounari, A., Gabrielli, A. F., Bertrand, S., Webster, J. P. and Fenwick, A. (2008). Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bulletin of the World Health Organization 86, 780-787.
145. Tsai, M. H., Marx, K. A., Ismail, M. M. and Tao, L. (2000). Randomly amplified polymorphic DNA (RAPD) polymerase chain reaction assay for identification of Schistosoma mansoni strains sensitive or tolerant to antischistosomal drugs. Journal of Parasitology 86, 146-149.
146. Valle, C., Troiani, A. R., Festucci, A., Pica-Mattoccia, L., Liberti, P., Wolstenholme, A., Francklow, K., Doenhoff, M. J. and Cioli, D. (2003). Sequence and level of endogenous expression of calcium channel beta subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel. Molecular and Biochemical Parasitology 130, 111-115.
147. van de Ven, R., Oerlemans, R., van der Heijden, J.W., Scheffer, G. L., de Gruijl, T. D., Jansen, G. and Scheper, R. J. (2009). ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer. Journal of Leukocyte Biology 86, 1075-1087. doi: 10.1189/jlb.0309147.
148. van der Werf, M. J., de Vlas, S. J., Brooker, S., Looman, C.W., Nagelkerke, N. J., Habbema, J. D. and Engels, D. (2003). Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Tropica 86, 125-139.
149. van Veen, H.W. (2010). Structural biology: last of the multidrug transporters. Nature 467, 926-927. doi: 10.1038/467926a.
150. Vennervald, B. J., Booth, M., Butterworth, A. E., Kariuki, H. C., Kadzo, H., Ireri, E., Amaganga, C., Kimani, G., Kenty, L., Mwatha, J., Ouma, J. H. and Dunne, D.W. (2005). Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 150-160.
151. Ventner, H., Shahi, S., Balakrishnan, L., Velamakanni, S., Bapna, A., Woebking, B. and van Veen, H.W. (2005). Similarities between ATPdependent and ion-coupled multidrug transporters. Biochemical Society Transactions 33, 1008-1011.
152. Vokál, I., Jirásko, R., Jedliková, V., Bártíková, H., Skálová, L., Lamka, J., Holapek, M. and Szotáková, B. (2012). The inability of tapeworm Hymenolepis diminuta and fluke Dicrocoelium dendriticum to metabolize praziquantel. Veterinary Parasitology 185, 168-174. doi: 10.1016/j.vetpar.2011. 09.026.
153. Wang, W., Dai, J. R., Li, H. J., Shen, X. H. and Liang, Y. S. (2010). Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China. Parasitology 137, 1905-1912. doi: 10.1017/S0031182010001204.
154. Wang,W., Dai, J. R., Li, H. J., Shen, X. H. and Liang, Y. S. (2012a). The sensitivity of Schistosoma japonicum to praziquantel: a field evaluation in areas with low endemicity of China. American Journal of Tropical Medicine and Hygiene 86, 834-836. doi: 10.4269/ajtmh.2012.11-0701.
155. Wang,W., Wang, L. and Liang, Y. S. (2012b). Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitology Research 111, 1871-1877. doi: 10.1007/s00436-012-3151-z.
156. Webster, J. P., Gower, C. M. and Norton, A. J. (2008). Evolutionary concepts in predicting and evaluating the impact of mass chemotherapy schistosomiasis control programmes on parasites and their hosts. Evolutionary Applications 1, 66-83. doi: 10.1111/j.1752-4571.2007.00012.x.
157. Welz, C., Kruger, N., Schniederjans, M., Miltsch, S. M., Krucken, J., Guest, M., Holden-Dye, L., Harder, A. and von Samson-Himmelstjerna, G. (2011). SLO-1-channels of parasitic nematodes reconstitute locomotor behaviour and emodepside sensitivity in Caenorhabditis elegans slo-1 loss of function mutants. PloS Pathogens 7, e1001330. doi: 10.1371/journal.ppat.1001330.
158. Wilkinson, R., Law, C. J., Hoey, E. M., Fairweather, I., Brennan, G. P. and Trudgett, A. (2012). An amino acid substitution in Fasciola hepatica P-glycoprotein from triclabendazole-resistant and triclabendazole-susceptible populations. Molecular and Biochemical Parasitology 186, 69-72. doi: 10.1016/j.molbiopara.2012.08.008.
159. William, S. and Botros, S. (2004). Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca2+-uptake as possible in vitro correlates to in vivo ED50 determination. International Journal for Parasitology 34, 971-977.
160. William, S., Botros, S., Ismail, M., Farghally, A., Day, T. A. and Bennett, J. L. (2001a). Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections. Parasitology 122, 63-66.
161. William, S., Sabra, A., Ramzy, F., Mousa, M., Demerdash, Z., Bennett, J. L., Day, T. A. and Botros, S. (2001b). Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. International Journal for Parasitology 31, 1093-1100.
162. Xianyi, C., Liying,W., Jiming, C., Xiaonong, Z., Jiang, Z., Jiagang, G., Xiaohua, W., Engels, D. and Minggang, C. (2005). Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992-2001). Bulletin of the World Health Organization 83, 43-48.
163. Xiao, S. H., Catto, B. A. and Webster, L. T., Jr. (1985). Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. Journal of Infectious Diseases 151, 1130-1137.
164. Xu, M., Molento, M., Blackhall, W., Ribeiro, P., Beech, R. and Prichard, R. (1998). Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Molecular and Biochemical Parasitology 91, 327-335.
165. Yang, Y., Jin, Y., Liu, P., Shi, Y., Cao, Y., Liu, J., Shi, Y., Li, H. and Lin, J. (2012). RNAi silencing of type V collagen in Schistosoma japonicum affects parasite morphology, spawning, and hatching. Parasitology Research 111, 1251-1257. doi: 10.1007/s00436-012-2959-x.
166. Yu, D. B., Li, Y., Sleigh, A. C., Yu, X. L., Li, Y. S., Wei, W. Y., Liang, Y. S. and McManus, D. P. (2001). Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 537-541.
167. Zhang, D., Chan, J. D., Nogi, T. and Marchant, J. S. (2011). Opposing roles of voltage-gated Ca2+ channels in neuronal control of regenerative patterning. Journal of Neuroscience 31, 15983-15995. doi: 10.1523/JNEUROSCI. 3029-11.2011.